Related Articles
Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancer
[Corrigendum] Synthesis and positron emission tomography evaluation of 18F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer
68Ga-PSMA PET/CT for the detection of bone metastasis in recurrent prostate cancer and a PSA level <2 ng/ml: Two case reports and a literature review
18F‑alfatide positron emission tomography may predict anti‑angiogenic responses
Expression, purification and identification of an immunogenic fragment in the ectodomain of prostate‑specific membrane antigen